Internal Medicine · El Paso, TX
NPI
1972524338
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2311 N Mesa St, Bldg B
El Paso, TX, 79902
Phone (915) 544-1533
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
3,022 services
Medicare patients, 2024
339
Average age 75
Drug cost, 2024
$5.5M
29,812 prescriptions
Company payments, 2025
$85K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammed R Alnajjar was code 99213 (office e&m - established), 773 times for 261 patients. In total Mohammed R Alnajjar billed 3,022 services in 29 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 773 | 261 | $57.75 | $45K |
| 82947 Clinical Chemistry | Office | 428 | 116 | $3.85 | $1,648 |
| 83036 Blood Count | Office | 319 | 114 | $9.52 | $3,037 |
| 99214 Office E&M - Established | Office | 223 | 141 | $82.74 | $18K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 205 | 205 | $17.74 | $3,636 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 198 | 198 | $17.73 | $3,511 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 194 | 194 | $123.77 | $24K |
| 99497 Care Management/Coordination | Office | 165 | 165 | $76.26 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 134 | 71 | $59.02 | $7,909 |
| 99223 Hospital E&M - Initial | Facility | 98 | 83 | $124.63 | $12K |
| 95923 Electrical Nerve Conductivity | Office | 77 | 76 | $90.05 | $6,934 |
| 99406 Behavioral Health Services | Office | 33 | 17 | $13.87 | $458 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 29 | 23 | $207.05 | $6,005 |
| 99204 Office E&M - New | Office | 23 | 23 | $86.93 | $1,999 |
| 99239 Hospital Discharge Management | Facility | 20 | 16 | $86.47 | $1,729 |
By year: 2022 $161K for 2,976 services; 2023 $173K for 3,355 services; 2024 $156K for 3,022 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 428 | 116 | $3.85 | $1,648 |
| 83036 Blood Count | 319 | 114 | $9.52 | $3,037 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammed R Alnajjar prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,511 prescriptions and refills. In total Mohammed R Alnajjar wrote 29,812 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,511 | 4,346 | 482 | $13K |
| Atorvastatin Calcium Generic | 1,164 | 3,317 | 411 | $8,797 |
| Rosuvastatin Calcium Generic | 988 | 2,896 | 390 | $10K |
| Gabapentin Generic | 941 | 2,394 | 433 | $21K |
| Losartan Potassium Generic | 931 | 2,668 | 320 | $7,413 |
| Amlodipine Besylate Generic | 849 | 2,416 | 335 | $4,110 |
| Lisinopril Generic | 836 | 2,427 | 288 | $5,551 |
| Omeprazole Generic | 774 | 2,216 | 312 | $15K |
| Carvedilol Generic | 722 | 2,063 | 263 | $4,909 |
| Metformin Hcl Generic | 696 | 2,002 | 259 | $4,631 |
| Meloxicam Generic | 609 | 1,732 | 334 | $2,889 |
| Simvastatin Generic | 608 | 1,754 | 202 | $5,183 |
| Montelukast Sodium Generic | 595 | 1,653 | 278 | $5,718 |
| Tamsulosin Hcl Generic | 531 | 1,523 | 217 | $6,266 |
| Metoprolol Succinate Generic | 491 | 1,398 | 179 | $5,738 |
Brand drugs: 4,920 claims; generic drugs: 24,354 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammed R Alnajjar $85K ($85K in general payments such as food, travel and fees) from 17 companies. The largest payer was Novo Nordisk Inc with $30K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $30K |
| Amgen Inc. AMGN | 31 | $19K |
| Phathom Pharmaceuticals, Inc. PHAT | 24 | $18K |
| Axsome Therapeutics, Inc. AXSM | 14 | $10K |
| Abbvie Inc. ABBV | 22 | $6,006 |
| Abbott Laboratories ABT | 5 | $363 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $281 |
| Ascensia Diabetes Care Us Inc. | 2 | $200 |
| Pfizer Inc. PFE | 20 | $190 |
| Ardelyx, Inc. ARDX | 13 | $140 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.